Professor Graham Lord is the Vice-President and Dean of the Faculty of Biology, Medicine and Health at the University of Manchester. He is also an attending Transplant Nephrologist at Manchester NHS Foundation Trust and Executive Director of the Manchester Academic Health Science Centre. He was previously the Professor of Medicine and Head of the Department of Experimental Immunobiology at King’s College London and the Director of the NIHR Biomedical Research Centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London from 2012-2019, where he retains an Honorary Professorship and Honorary attending status.​

He qualified in medicine from Cambridge and trained at the Hammersmith Hospital, Oxford and Imperial College as a physician-scientist. Following postdoctoral training at Harvard University, he moved back to the UK in 2006 and established a research group based on the regulation of lymphocyte gene expression in the context of mucosal homeostasis and auto-inflammatory disease. He has clinical interests in multi-organ transplantation, the diagnosis and treatment of long-term allograft failure and adoptive cellular therapy for the treatment of autoimmunity. He also has a long-term interest in academic healthcare ecosystems and how they can drive improvements to human health in a sustainable manner and co-founded Gritstone Oncology (now Gritstone Bio) in 2015, which went public in 2018.